These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12144534)

  • 1. Enrichment of normal progenitors in counter-flow centrifugal elutriation (CCE) fractions of fresh chronic myeloid leukemia leukapheresis products.
    Dlubek D; Dybko J; Wysoczanska B; Laba A; Klimczak A; Kryczek I; Konopka L; Lange A
    Eur J Haematol; 2002 May; 68(5):281-8. PubMed ID: 12144534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCR/ABL-negative progenitors are enriched in the adherent fraction of CD34+ cells circulating in the blood of chronic phase chronic myeloid leukemia patients.
    Grand FH; Marley SB; Chase A; Titley I; Healy L; Spencer A; Reiter A; Goldman JM; Gordon MY
    Leukemia; 1997 Sep; 11(9):1486-92. PubMed ID: 9305602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of BCR/ABL-negative primitive hematopoietic progenitor cells within chronic myeloid leukemia marrow.
    Leemhuis T; Leibowitz D; Cox G; Silver R; Srour EF; Tricot G; Hoffman R
    Blood; 1993 Feb; 81(3):801-7. PubMed ID: 7679000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCR/ABL- CD34(+)HLA-DR- progenitor cells in early chronic phase, but not in more advanced phases, of chronic myelogenous leukemia are polyclonal.
    Delforge M; Boogaerts MA; McGlave PB; Verfaillie CM
    Blood; 1999 Jan; 93(1):284-92. PubMed ID: 9864172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood is a source of BCR-ABL-negative pre-progenitors in early chronic phase chronic myeloid leukemia.
    Lewis ID; Haylock DN; Moore S; To LB; Hughes TP
    Leukemia; 1997 Apr; 11(4):581-7. PubMed ID: 9096699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCR-ABL expression in different subpopulations of functionally characterized Ph+ CD34+ cells from patients with chronic myeloid leukemia.
    Maguer-Satta V; Petzer AL; Eaves AC; Eaves CJ
    Blood; 1996 Sep; 88(5):1796-804. PubMed ID: 8781437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation at single cell level of residual Philadelphia negative hemopoietic stem cells in chronic phase CML patients.
    Akel S; Kolialexi A; Mavrou A; Metaxotou C; Loukopoulos D; Yataganas X
    Cancer Genet Cytogenet; 2000 Oct; 122(2):93-100. PubMed ID: 11106818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The BCR/ABL transgene causes abnormal NK cell differentiation and can be found in circulating NK cells of advanced phase chronic myelogenous leukemia patients.
    Nakajima H; Zhao R; Lund TC; Ward J; Dolan M; Hirsch B; Miller JS
    J Immunol; 2002 Jan; 168(2):643-50. PubMed ID: 11777957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign marrow progenitors are enriched in the CD34+/HLA-DRlo population but not in the CD34+/CD38lo population in chronic myeloid leukemia: an analysis using interphase fluorescence in situ hybridization.
    Kirk JA; Reems JA; Roecklein BA; Van Devanter DR; Bryant EM; Radich J; Edmands S; Lee A; Torok-Storb B
    Blood; 1995 Jul; 86(2):737-43. PubMed ID: 7541674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.
    Misawa M; Maeda H; Hara H; Yamamoto Y; Furuyama J
    Stem Cells; 1993 Nov; 11(6):536-42. PubMed ID: 7509222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukemic burden in subpopulations of CD34+ cells isolated from the mobilized peripheral blood of alpha-interferon-resistant or -intolerant patients with chronic myeloid leukemia.
    Van den Berg D; Wessman M; Murray L; Tong J; Chen B; Chen S; Simonetti D; King J; Yamasaki G; DiGiusto R; Gearing D; Reading C
    Blood; 1996 May; 87(10):4348-57. PubMed ID: 8639795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence in situ hybridization for the BCR/ABL rearrangement is dependent on the percentage of nonlymphocytic cells in peripheral blood stem cell harvests.
    Bornhäuser M; Mohr B; Ehrenlechner U; Neubauer A; Ehninger G
    J Hematother; 1998 Oct; 7(5):425-30. PubMed ID: 9829316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PBPC mobilization with chemotherapy and G-CSF in patients with chronic myeloid leukemia: quantification of bcr/abl-positive cells by interphase fluorescence in situ hybridization and competitive PCR.
    Keil F; Mitterbauer G; Chen X; Haas OA; Kalhs P; Lechner K; Mannhalter C; Moser K; Worel N; Pirc-Danoewinata H; Louda N; Loidolt H; Rabitsch W; Greinix HT
    Transfusion; 2001 Jan; 41(1):111-6. PubMed ID: 11161255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells.
    Veena P; Cornetta K; Davidson A; Agüero B; McMahel J; Traycoff CM; Srour EF
    Bone Marrow Transplant; 1997 Jun; 19(12):1213-21. PubMed ID: 9208115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purging of peripheral blood stem cells yields BCR-ABL-negative autografts in patients with BCR-ABL-positive acute lymphoblastic leukemia.
    Martin H; Atta J; Zumpe P; Eder M; Elsner S; Rode C; Wassmann B; Bruecher J; Hoelzer D
    Exp Hematol; 1995 Dec; 23(14):1612-8. PubMed ID: 8542955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Separation of G-CSF-mobilized PBSC transplants by counterflow centrifugal elutriation: modest enrichment of CD34+ cells but no loss of primitive haemopoietic progenitors.
    Kwekkeboom J; Buurman DE; van Hennik PB; Ploemacher RE; Loos HA; Slaper-Cortenbach IC
    Br J Haematol; 1997 Oct; 99(1):47-55. PubMed ID: 9359501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCR/ABL-negative clonogenic hematopoietic cells do not accumulate in the plastic-adherent fraction of peripheral blood mononuclear cells from patients with chronic myeloid leukemia in stable chronic phase.
    Schultheis B; Pasternak G; Hehlmann R
    Folia Biol (Praha); 2000; 46(6):256-63. PubMed ID: 11140859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of IL-3 and G-CSF-mobilized peripheral blood stem cells in patients with early chronic phase CML.
    Heinzinger M; Waller CF; Rosenstiel A; Scheid S; Burger KJ; Lange W
    Leukemia; 1998 Mar; 12(3):333-9. PubMed ID: 9529127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypersensitivity of bcr-abl-positive progenitors to hyperthermia in patients with chronic myeloid leukemia.
    Thijsen SF; van Oostveen JW; Schuurhuis GJ; Theijsmeijer AP; Oudejans CB; van Wijk IJ; Langenhuijsen MM; Ossenkoppele GJ
    Leukemia; 1997 Oct; 11(10):1762-8. PubMed ID: 9324298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of BCR/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia.
    Primo D; Flores J; Quijano S; Sanchez ML; Sarasquete ME; del Pino-Montes J; Gaarder PI; Gonzalez M; Orfao A
    Br J Haematol; 2006 Oct; 135(1):43-51. PubMed ID: 16939497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.